1286653-21-1
1286653-21-1
Chemical Structure
CX516-d10
Synonym(s): BDP 12-d10
- CAS No.: 1286653-21-1
- Formula:C14H5D10N3O
- Molecular Weight:251.35
IUPAC Name: (piperidin-1-yl-d10)(quinoxalin-6-yl)methanone
InChIKey: ANDGGVOPIJEHOF-YRRFPNITSA-N
SMILES: O=C(N1C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H])C2=CC3=C(N=CC=N3)C=C2
Biological Activity: CX516-d10 is the deuterium labeled CX516. CX516 (BDP 12) is an ampakine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CX516-d10 | CX516-d10 is the deuterium labeled CX516. CX516 (BDP 12) is an ampakine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CX516 | 99.94% | CX516 (BDP 12) is an ampakine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
